| 
We
at BioCure wish to communicate with a broad spectrum of medical
professionals. In this section, we will make available BioCure's
clinical publications and medical releases beginning with our presence
at CIRSE in September 2001.
We
intend to be present and participate in the foremost worldwide conferences
with an initial and primary focus on interventional radiology.
Following
CIRSE, we will participate at ISET
in January 2002 and the largest interventional meeting at the
US society, SCVIR, in April 2002.
In
the meantime, we will regularly update the site with any relevant
medical releases including news on new products, new therapies and
our ongoing clinical program.
We
will be contacting many medical professionals over the next weeks
and months to gauge the feedback on our activities and on our clinical
programs as well as asking you what more you'd like to hear about
from our Web site.
As
always, please feel free to contact
us at any time.
Abstracts
::
"An
in situ Curing Hydrogel Used as a Liquid Embolic Agent for Transcatheter
Therapy. Preliminary in vitro and in vivo Experience"
to be presented by Dr. Doug Redd MD of Emory University Hospital
at CIRSE in September 2001.
::
"Evaluation of Endoleak Management Techniques in an Experimental
Abdominal Aortic Aneurysm (AAA) Flow Model Under Physiologic Conditions"
to be presented by Dr. Doug Redd MD of Emory University Hospital
at CIRSE in September 2001.
These
abstracts have not been reviewed by the United States Food and Drug
Administration and are for informational purposes only.
|